baber/WOPTO huggingface dataset:
Patent CA-3167459-A1 (CA)
Title: Calcination process
Inventor: KRUGER TIM
IPC: B01D53/34
Filed: 2021-02-11
Abstract: Described is the use of a mineral comprising a metal carbonate fraction and a fuel fraction, such as oil shale or coal shale, in a calcination process. The disclosed process can advantageously result in carbon dioxide being removed from the atmosphere. Further, in the process, heat energy generated during calcination can be used to separate oxygen from air, so that the oxygen can be fed back into the system. Alternatively or in addition, heat energy may also be used to compress the gaseous carbon dioxide generated from the calcination process.
Patent CA-3168156-A1 (CA)
Inventor: LAHAYE THIERRY
IPC: G06N10/00
Filed: 2021-02-12
Abstract: A quantum-computing device comprising:?an atom-trapping unit configured to generate a three-dimensional array (M3P) of optical tweezers in an ultra-high-vacuum chamber (EV);?an atom source (SAT), for generating a beam of atoms (JA) that is directed toward the space containing the three-dimensional array of optical tweezers;?a magneto-optical system (SM) for cooling the atoms, said system being configured to generate, in the space containing the array, a gray molasses; and?a system (SPQ) for applying quantum logic gates to atoms trapped in the optical tweezers of the array; and-a cryostat for establishing a cryogenic temperature in the ultra-high-vacuum chamber;the atom-trapping unit comprising two lens-holding barrels (B1, B2) placed facing, each barrel holding one of said aspherical lenses with a sufficient clearance to compensate for a differential in thermal contraction between the barrel and the lens during a passage from an ambient temperature to a cryogenic temperature.
Patent CA-3168259-A1 (CA)
Inventor: FRENCH JORDAN ROBERT
IPC: B65D85/00
Filed: 2019-03-07
Abstract: A package with a selectively openable case and tray to selectively allow access to one or more compartments is disclosed.
Patent CA-3171519-A1 (CA)
Title: Antimicrobial protein and relative uses
Inventor: PAPARELLA ALESSANDRO
IPC: A61P31/02
Filed: 2021-03-12
Abstract: The invention relates to a synthetic fusion protein having high antimicrobial activity. In particular, the invention relates to the use of said protein to eliminate pathogenic microorganisms from environments and surfaces. In particular, the synthetic fusion protein object of the present invention can be used in the preparation of disinfectant solutions that can be used in the outpatient, hospital and domestic field, in high traffic environments, in filters of air inlet and extraction systems or air conditioners or air treatment unit ATU, in environments used for food preparation. In general, in all those areas where it is necessary to adopt antimicrobial prophylaxis directed against gram + bacteria, viruses, mycoplasma and fungi.
Patent CA-3174765-A1 (CA)
Title: Electronic tape measure
Inventor: BARGETZI ANDRI
IPC: G01B3/1069
Filed: 2021-03-30
Abstract: An electronic tape measure for measuring a body part comprises a housing with a tape outlet opening, a tape drum which is rotatably mounted about an axis of rotation in the housing, and a tape with length markings which is fastened, by an inner end, to the tape drum, can be wound onto the latter and can be guided out of the tape outlet opening. The axis of rotation defines an axial, a radial and an azimuthal direction. The tape measure also comprises the following modules: a read-out module which is configured to read out the markings; a data processing module which is connected to the read-out module and is configured to provide a measurement instruction for the user and to process a length measured value which has been read out; an input module which is connected to the data processing module and is configured to receive an input from the user; and a display module which is connected to the data processing module, is configured to display the measurement instruction and is arranged on the housing in a radial-azimuthal plane, wherein the display module comprises a screen.
Patent CA-3175746-A1 (CA)
Title: Procede de traitement de revetement par plasma pour inhiber le transfert de pathogenes biologiques
Inventor: HEYBERGER REGIS
IPC: A01N37/36
Filed: 2021-03-17
Abstract: La présente invention concerne un procédé de fourniture d'une couche bioactive sur une surface, comprenant les étapes suivantes : a) l'ionisation d'un gaz plasma à basse température de 150 °C ou moins, et à environ la pression atmosphérique, créant ainsi un plasma ; b) l'introduction d'un précurseur dans ledit plasma ; c) l'exposition de la surface audit plasma comprenant ledit précurseur, formant ainsi un revêtement sur ladite surface, caractérisé en ce que les précurseurs comprennent un composé inhibant le transfert de pathogènes biologiques.
Patent CA-3176913-A1 (CA)
Title: Connector for patient interface with slide locking mechanism
Inventor: PEACOCK MATHEW IAN
IPC: A61M16/16
Filed: 2015-06-18
Abstract: This invention relates to a patient interface and component parts which may be integrated or form a part of an assembled interface for use by a user. In various embodiments, the component parts may include: a component may be provided as a clip for supporting a gas supply tube to the interface; a buckle may be provided at an end of a headgear strap for releasable attachment to the interface; a manifold part of a patient interface may be attachable to the interface in a manner allowing for adjustment or re-orientation such that an associated gas supply conduit is re-routed to be to a left- or a right-side of the interface (or user); one or a pair of support side arms of the interface may be configured to be twisted or bent so as to more comfortably accommodate the shape of a user's face upon which they are to be located in use; parts of a manifold at the connection of a gas supply tube to the interface may be configured to be of a multi-part manifold assembly.
Patent CA-3177910-A1 (CA)
Inventor: WORKMAN MICHAEL
IPC: G16H20/17
Filed: 2021-05-03
Abstract: A medical device is configured to store, in a session memory, data regarding operational parameters of the medical device, changes to the parameters, and physiological data of a patient associated with the medical device. A clinician may select, via a user interface of the medical device, a portion of the session memory to a remote device with a request for assistance regarding a problem occurring at the medical device. The portion of the session may be reviewed at the remote device in a graphical copy of a user interface of the medical device as it appeared when the data was recorded, and a workflow is generated at the remote device and sent to the medical device to assist the clinician in resolving issues at the medical device. A session may be started without an identification of the patient or a medical component, and the identification updated at a later time.
Patent CA-3179222-A1 (CA)
Inventor: MOLLICK PETER J
IPC: A61K36/40
Filed: 2021-04-01
Abstract: L'invention concerne un traitement thérapeutique pour le traitement de la maladie COVID -19, le traitement devant être initié rapidement après et de préférence environ vingt-quatre heures après que le patient développe les premiers signes de symptômes comprenant, mais sans y être limités, individuellement ou en combinaison, la fièvre, les maux de tête, les douleurs articulaires, la toux, la fatigue, les frissons. Le traitement consiste en l'administration orale de thym, également connu sous le nom de thym commun (Thymus vulgaris). Le traitement est supposé inhiber la réplication et l'activité du virus permettant au patient de retrouver une santé normale et l'aide à développer une immunité contre le virus. Le traitement n'est pas reconnu pour éliminer complètement le virus du patient, ce qui fait que le patient peut développer les mêmes symptômes ou des symptômes différents de la maladie une deuxième fois ou plus, ce qui nécessite des traitements supplémentaires du traitement thérapeutique au thym décrit.
Patent CA-3179590-A1 (CA)
Title: Systeme de participation a distance
Inventor: MURUGAN CHANDRASAGARAN
IPC: H04N7/14
Filed: 2021-05-20
Abstract: Un système de participation à distance associé à un événement en direct se produisant en un lieu comprend un dispositif de sortie situé au niveau du lieu ou à distance du lieu et conçu pour fournir une sortie audio et/ou visuelle à au moins un destinataire. Un dispositif de commande reçoit des signaux, ces signaux représentant des réactions physiques de spectateurs à distance et étant émis par une pluralité de dispositifs d'entrée d'utilisateurs situés à distance les uns des autres et émis à partir du lieu, et commande le dispositif de sortie situé au niveau du lieu ou à distance du lieu de façon à fournir une sortie audio et/ou visuelle à des personnes au niveau du lieu ou situées à distance du lieu.
Patent CA-3180092-A1 (CA)
Inventor: DARNELL ROBERT B
IPC: C12Q1/6806
Filed: 2021-05-28
Abstract: The present invention provides methods for isolation and characterization of nucleic acid, particularly RNA, from small volume and self-collected samples, including fingerstick blood samples, swabs and saliva samples. The RNA derived is intact and of sufficient quality and quantity for RNA analysis, longitudinal RNA sequencing and global transcriptomic profiling.
Patent CA-3180252-A1 (CA)
Title: Systeme optique utilisant une capture de frange statique amelioree
Inventor: LAPLANTE CURTIS
IPC: G01B9/02
Filed: 2021-06-14
Abstract: Un procédé de soustraction d'arrière-plan et un dispositif d'étage d'inclinaison permettant d'éliminer des motifs d'interférence contaminés ou parasites par la réduction des erreurs de retour de faisceau. Une surface de référence optique fixée dans une monture pivotante couplée à un actionneur d'inclinaison est configurée pour déplacer angulairement la monture pivotante et la surface de référence optique. Un microcontrôleur couplé à l'actionneur d'inclinaison commande le déplacement d'inclinaison de l'actionneur d'inclinaison en fournissant une pluralité de mesures de front d'onde de la surface de référence à une pluralité d'angles afin de fournir un système et un procédé de mesure d'arrière-plan.
Patent CA-3181510-A1 (CA)
Title: Method and analyzer to correct for unknown interferences in a patient blood sample
Inventor: JASPERSE JEFFREY R
IPC: G01J3/02
Filed: 2021-06-09
Abstract: Analyzers and methods of use are disclosed, including a blood analyzer comprising a light source to transmit an optical signal; a detector to generate data indicative of optical signal intensity; a transparent sample vessel between the light source and the detector; a dispensing device to pass a first portion of the blood sample comprising whole blood or lysed blood into the vessel at a first instance of time, and to pass a plasma portion of the blood sample into the vessel at a second instance of time; a controller to cause a processor to obtain first and second data generated by the detector, the first data indicative of the optical signal passing through the first portion of the blood sample and the second data indicative of the optical signal passing through the plasma, to determine a total absorbance spectrum in which the first data is adjusted by the second data.
Patent CA-3182943-A1 (CA)
Inventor: MACFARLANE IAN
IPC: F16J15/447
Filed: 2022-11-25
Abstract: A labyrinth seal assembly comprising: an outer seal having a radially inner cavity surface, and an axial cavity surface inward of the radially inner cavity surface; a floating seal received by the outer seal so as to be movable in a radial direction relative to the outer seal, the floating seal having a radially outer seal surface spaced inwardly from the radially inner cavity surface, a radially inner surface inward of the radially outer seal surface, and an axial seal surface bearing against the axial cavity surface; and an inner seal received by the floating seal, the inner seal having a radially outer surface spaced inwardly from the radially inner surface, a first one of the radially outer surface and the radially inner surface defining one tooth projecting toward a second one of the radially outer surface and the radially inner surface to inward of the axial seal surface.
Patent CA-3184562-A1 (CA)
Inventor: MAYERHOEFFER ULRICH
IPC: C07C65/34
Filed: 2021-08-16
Abstract: La présente invention concerne un procédé de préparation de phénylcétones et la préparation de dérivés de phénoxyphényle.
Patent CA-3187433-A1 (CA)
Inventor: AMEISS KEITH ALLEN
IPC: C12N5/07
Filed: 2021-06-15
Abstract: The present application relates to an avian cell line capable of supporting viral growth of Marek's Disease Virus (MDV), including Herpes Virus of Turkeys (HVT), methods of producing such cell lines, and therapeutic uses of the cell lines and resulting vaccines.
Patent CA-3188014-A1 (CA)
Title: Anti-trop2 antibody
Inventor: ZHU YI
IPC: G01N33/53
Filed: 2021-06-18
Abstract: Provided are monovalent and multivalent anti-TROP2 antibodies. Such antibodies specifically bind to TROP2 protein, have a strong relative affinity and high endocytosis efficiency. The specific antibody has a wide application prospect in the development of ADC drugs. The present invention also relates to a murine monoclonal antibody, a human-murine chimeric antibody, a humanized antibody, and the use of such antibodies in the diagnosis and treatment of tumors.
Patent CA-3189994-A1 (CA)
Inventor: BANDIERA MASSIMO
IPC: C04B28/14
Filed: 2021-08-25
Abstract: A cement-reduced construction composition comprises a) a cementitious binder comprising one or more calcium silicate mineral phases and one or more calcium aluminate mineral phases, and having a Blaine surface area of at least 3800 cm2/g, in an amount of 180 to 400 kg per m³ of the freshly mixed construction composition; b) a fine material having a Dv90 of less than 200 µm, selected from alkali-activatable binders, rock powders and inorganic pigments, or mixtures thereof, in a total amount of 20 to 200 parts by weight, relative to 100 parts by weight of cementitious binder a); c) optionally, an extraneous aluminate source; d) a sulfate source; and e) a polyol in an amount of 0.3 to 2.5 wt.-%, relative to the amount of cementitious binder a). The composition contains available aluminate, calculated as Al(OH)4?, from the calcium aluminate mineral phases plus the optional extraneous aluminate source, per 100 g of cementitious binder a), in a total amount of at least 0.08 mol, if the amount of cementitious binder a) is in the range of 180 to less than 220 kg per m³ of the freshly mixed composition, at least 0.06 mol, if the amount of cementitious binder a) is in the range of 220 to less than 280 kg per m³ of the freshly mixed composition, and at least 0.05 mol, if the amount of cementitious binder a) is 280 kg or more per m³ of the freshly mixed composition; and the molar ratio of total available aluminate to sulfate is 0.4 to 2Ø The construction composition further comprises f) an ettringite formation controller comprising (i) glyoxylic acid, a glyoxylic acid salt and/or a glyoxylic acid derivative; and (ii) at least one of (ii-a) a borate source and (ii-b) a carbonate source, wherein the carbonate source is selected from inorganic carbonates having an aqueous solubility of 0.1 g·L-1 or more, organic carbonates, and mixtures thereof; and g) a co-retarder selected from (g-1) ?-hydroxy monocarboxylic acids and salts thereof, (g-2) phosphonic acids and salts thereof, (g-3) polycarboxylic acids and salts thereof, and mixtures thereof. The cement-reduced construction composition is a reduced carbon footprint construction composition and exhibits high early strength, high final strength, sufficient open time, high durability, and reduced shrinkage compared to ordinary Portland cement based mixes. Ingredients of the construction composition are abundantly available.
Patent CA-3190092-A1 (CA)
Inventor: MUERDTER FELIX
IPC: G16B5/20
Filed: 2021-08-20
Abstract: A computational framework for generating and predicting regulatory sequences is described.
Patent CA-3194913-A1 (CA)
Title: System and method for unmanned or undermanned delivery of restricted products
Inventor: HURRY JON PATRICK
IPC: G06Q20/18
Filed: 2021-10-13
Abstract: A system and method for delivering restricted products. The delivery system may include a user device, an external server, and a delivery unit. A user can register to use the system by verifying their identity and recording at least one biometric characteristic with the user device. When a user selects a restricted product for purchase at the delivery unit, the user's identity may be verified, the user's presence at the delivery unit may be verified through a liveness check and/or a location determination, the user's eligibility to purchase the selected product may be determined, and the user's ability to pay for the selected products may be determined. If the external server determines the user is eligible to purchase the selected product, the external server can send a delivery command to the delivery unit and the delivery unit may allow the user to have access to the purchased product.
Patent CA-3199091-A1 (CA)
Inventor: DAKE BEN
IPC: A61K47/26
Filed: 2021-11-23
Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
Patent CA-3203669-A1 (CA)
Title: Dispositif de montage a la presse, gabarit de montage a la presse, et dispositif de fabrication
Inventor: ASAI RYOTA
IPC: B23P19/02
Filed: 2021-11-17
Abstract: Le dispositif de montage à la presse (10) de l'invention possède une partie support (22), et un mécanisme de pressage (30) possédant un outil de montage à la presse (32) mobile. L'outil de montage à la presse (32) est équipé : d'une partie pressage (33) pressant un composant montage à la presse (A) au moyen d'une face pressage (33a) ; d'une partie régulation (34) pouvant venir en contact avec un composant à monter à la presse (B) au moyen d'une face régulation (34a) ; et d'un mécanisme d'établissement de position (40) qui établit la position de pressage dans la direction de pressage de la face pressage (33a) et la position de régulation dans la direction de montage à la presse de la face régulation (34a), en fonction du composant montage à la presse (A) et du composant à monter à la presse (B).
Patent CA-3208320-A1 (CA)
Title: Apparatus for mixing in catalytic cracker reactor
Inventor: LUDOLPH ROBERT ALEXANDER
IPC: B01J8/00
Filed: 2022-02-01
Abstract: The present invention provides a catalytic cracking reactor comprising a conduit, configured to allow the passage of a flow of catalyst particles, and an injection zone comprising a ring of feed injectors extending inwardly from the wall of reactor and angled to inject feed into the flow of catalyst particles, characterised in that the reactor also comprises a contacting device protruding into the reactor from the inner wall of said reactor upstream of the injection zone. The present invention also provides a method of mixing a fluidised stream of catalyst particles with a hydrocarbon feed, said method comprising the steps of: a) creating a stream of fluidised catalyst particles in a reactor; b) passing said stream of fluidised catalyst particles past a contacting device protruding into the reactor from the inner wall of said reactor; c) subsequently passing the stream of fluidised catalyst particles through an injection zone comprising a ring of feed injectors extending inwardly from the wall of the reactor and contacting said stream of fluidised catalyst particles with hydrocarbon feed provided through said feed injectors; d) passing the stream of fluidised catalyst particles contacted with hydrocarbon feed to a downstream section of the reactor to convert the hydrocarbon feed to a converted product in the presence of the catalyst particles.
Patent CA-3209481-A1 (CA)
Title: Procedes et compositions de congelation et de decongelation de cellules de mammifere
Inventor: ZHOU SHUXIA
IPC: A01N1/02
Filed: 2022-02-09
Abstract: La présente divulgation concerne, entre autres, un procédé de cryoconservation et de décongélation de cellules qui conduit à des cellules décongelées présentant une viabilité cellulaire et une fonctionnalité élevées après décongélation. Dans certains modes de réalisation, l'invention concerne un procédé à grande échelle de cryoconservation de cellules, le procédé consistant à : (a) mettre en contact les cellules avec un milieu de cryoconservation ; (b) refroidir les cellules à -80 °C à une vitesse régulée afin de réduire au minimum l'enthalpie de fusion ; et (c) stocker les cellules en phase vapeur d'azote liquide, ce qui permet de cryoconserver les cellules immunitaires.
Patent CA-3211070-A1 (CA)
Title: Regeneration and multiple use of depth filters
Inventor: FALKENSTEIN ROBERTO
IPC: C07K1/34
Filed: 2022-02-21
Abstract: Herein is reported a method for the purification or production of a therapeutic polypeptide using the same depth filter multiple times, i.e. a depth filter which has been used before and has been regenerated. Reported herein is a method for purifying or producing a therapeutic polypeptide, characterized in that the method comprises the following steps: a) filtering an aqueous composition containing said therapeutic polypeptide and impurities through a depth filter, recovering the flow-through and thereby obtaining said purified therapeutic polypeptide, b) contacting said depth filter with a regeneration solution and thereby regenerating the depth filter, and c) repeating steps a) and b) one or more times.
Patent CA-3216637-A1 (CA)
Title: Batiments transportables pliables
Inventor: TIRAMANI PAOLO
IPC: E04B1/14
Filed: 2022-02-18
Abstract: L'invention concerne un système d'espacement pour des structures de construction empilées qui est en prise d'accouplement avec une plaque d'étanchéité disposée sur un bord d'un composant d'enceinte, et un agencement de tube de fourche pour faciliter le mouvement d'un module d'expédition.
Patent CA-3217225-A1 (CA)
Title: Method of increasing chaperone mediated autophagy by stabilizing the interaction of retinoic acid receptor-alpha and an inhibitor
Inventor: CUERVO ANA MARIA
IPC: A61K31/498
Filed: 2022-04-21
Abstract: This disclosure provides a method of stabilizing the interaction of a Retinoic Acid Receptor- alpha (RARa) and a corepressor, Nuclear Receptor Corepressor 1 (NCoRl) by contacting the RARa with an amount of a Chaperone Mediated Autophagy (CMA) Activator sufficient to stabilize the RARa-NCoRl interaction. Stabilizing the RARa/ corepressor interaction can prevent a neurodegenerative disorder in a subject at risk for developing the neurodegenerative disorder or slow the advancement of a neurodegenerative disorder in a subject having an early symptom or biomarker of the neurodegenerative disorder. The disclosure also provides a method of maintaining preventing or slowing the advancement of a retinal degenerative disorder in a subject having an early symptom or biomarker of the retinaldegenerative disorder. The neurodegenerative disorder can be Alzheimer's disease (AD),Lewy body dementia, Parkinson's disease (PD), Huntington's disease,.Amyotrophic lateralsclerosis (ALS), Frontotemporal dementia (FTD), Spinocerebellar ataxias (SCAs). The retinal degenerative disorder can be retinitis pigmentosa.
Patent CA-3218168-A1 (CA)
Title: Topical compositions containing manuka oil and palmarosa oil for treating skin conditions
Inventor: GILMOUR ROBERT
IPC: A61K8/99
Filed: 2022-05-06
Abstract: A topical composition for treatment of a skin condition comprising a mixture of Leptospermum scoparium oil (manuka oil or ?-triketones extracted from manuka oil), at least one of Cymbopogon martinii (palmarosa oil), CBD oil or isolate, or Pogostemon cablin (patchouli oil), and a carrier composition.
Patent CA-3218361-A1 (CA)
Title: Amarouciaxanthin a esters and uses thereof
Inventor: GARCIA-DELGADO BANCHS NOEMI
IPC: C07C403/24
Filed: 2022-07-18
Abstract: The present invention relates to compound of formula (I) or a stereoisomer thereof, in particular amarouciaxanthin A acetate. The invention also relates to the method of preparation of these compounds, to compositions comprising them as well as their medical and cosmetic uses.